KRAS and intrahepatic cholangiocarcinoma: Choi et al. analyzed KRAS mutation in liver tumors comprising 4 hepatocellular carcinoma, 7 intrahepatic cholangiocarcinoma (ICC), 1 neuroendocrine carcinoma, and 16 metastatic cancer with EUS-FNB specimens and next-generation sequencing [51].